Antiserum generated in a horse against testosterone conjugated to bovine serum albumin (BSA) was administered to six lighthorse mares (androgen-immunized mares ) 1 to 3 d before a prostaglandin-induced estrus and twice again at 2-d intervals. Six control mares were administered antiserum generated against BSA on the same schedule. Relative to testosterone, cross-reactivities of other steroids with the testosterone antiserum were (%): dihydrotestosterone, 52; 5a-androstane3a,17#-diol, 8.6; androst-4-ene-3,17-dione, 1.2; and all others tested <.1. Tritiated testosterone binding in plasma increased (P<.01) in androgen-immunized mares within i h and remained elevated (P<.O1) relative to controls for >21 d. There was no effect (P>.lO) of passive immunization against androgen on interval to estrus after prostaglandin injection, duration of estrus, ovarian volume, number of palpable follicles or follicular volume during estrus. In contrast, concentrations of luteinizing hormone (LH) were higher (P<.05) in androgen-immunized mares than in control mares during estrus and eaxly diestrus. Concentrations of follicle stimulating hormone (FSH) and progesterone at those times were not affected (P>.IO). From these data, we conclude that androgens in the mare during estrus may be involved with the regulation of LH secretion. In contrast, no involvement with FSH secretion was apparent under these short-term conditions.
I ntroduction
Androgens such as testosterone and androstenedione have been shown to increase in serum of mares during estrus (Noden et al., 1975; Silberzahn et al., 1978) . Treatment of intact and ovariectomized mares with testosterone propionate (TP) increased the follicle stimulating hormone (FSH) response to exogenous gonadotropin releasing hormone (GnRH), but decreased the daily secretion of luteinizing hormone (LH; Thompson et al., 1983c Garza et al., 1986) . RevilleMoroz et al. (1984) reported that the TP-induced increase in FSH secretion after exogenous GnRH was due in part to increased de novo FSH production. Moreover, treatment of cyclic t Send reprint requests to D. L. Thompson, Jr., Anita. Sci. Dept., Louisiana State Univ., Baton Rouge, LA 70803.
2Anim. Sei. Dept., Louisiana Agr. Exp. Sta. Received June 10, 1986 . Accepted November 25, 1986 mares with testosterone during estrus increased FSH secretion during the subsequent diestrus (Thompson et al., 1983d ). An alternative approach for studying the possible involvement of a hormone in various systems is active or passive immunization against the hormone (Nieshlag et al., 1974) . For example, active immunization against androstenedione or testosterone increased gonadotropin secretion and ovarian activity in ewes Scaramuzzi et al., 1981) . Immunization against androstenedione also increased ovulation rate in heifers (Wise and Schanbacher, 1983) . Thus, the present experiment was designed to study the possible involvement of androgens in the reproductive processes of the mare by passive immunization at estrus.
Materials and Methods
Twelve lighthorse mares between 3 and 12 yr old were kept on pasture and were supplemented with grass hay as needed to maintain 797 J. Anita. Sci. 1987. 64:797--804 good body condition. Mares were checked for estrus daily beginning February 1. By April 1, all mares had displayed at least three consecutive days of estrus followed by at least eight consecutive days of diestrus. On the first day of estrus after April 1, each mare was allotted to either the androgen-immunized (n=6) or the control group (n=6), and was started on a schedule of daily blood sampling via jugular venipuncture. This first estrus was designated Estrus I. Mares were monitored in this manner through Diestrus I and the subsequent estrus (Estrus II), and then into the subsequent diestrus (Diestrus II). The duration of Diestrus I was then used to predict the day of onset of Estrus III; 3 d before this calculated onset of estrus, each mare was administered prostaglandin F2a (PG) to cause luteal regression. A second PG injection was given 24 h after the first. One day following the second PG injection, each mare was administered 100 ml of the appropriate antiserum (described later) iv immediately after the daily blood sample had been drawn. Additional blood samples were drawn at 1, 2, 4 and 8 h after injection of antiserum. On the following day, mares were started on a twice-daily blood sampling schedule (0800 and 1600). Secondary injections of antiserum (25 ml) were administered iv 48 and 96 h after the first to ensure that a constant amount of binding activity was present throughout estrus. Twice-daily blood sampling was continued through Estrus III and Diestrus III. The ovaries of each mare were assessed by palpation per rectum on the second day of Estrus III and on alternate days thereafter until the end of estrus. The length, width and depth of each ovary and the number and size of palpable follicles were estimated and recorded. Ovarian volume (cm 3) was the product of length, width and depth. Follicular volume was calculated from the estimated diameter using the formula for a sphere (v = 4/3zrr 3).
Testosterone antiserum was generated in a pony mare against testosterone-3-oxime conjugated to bovine serum albumin (BSA; Erlanger et aI., 1959) . Another pony was immunized against BSA. After several secondary immunizations, blood was harvested and heparinized plasma was prepared. A gamma globulin-enriched fraction of each plasma pool was obtained by (NH4)2SO4 precipitation (50% saturation). The precipitates were dissolved in a minimum amount of water and were dialyzed against water followed by .9% saline. The final solutions, which were concentrated by about twofold (based on testosterone binding by the anti-androgen pool), were then sterilized by gamma irradiation. Less than 3% of the testosterone-binding capacity of the anti-androgen pool was lost during sterilization. The ability (relative to testosterone) of various steroids to inhibit the binding of tritiated testosterone to the antiserum was determined as described by Thompson and Honey (1984) for estradiol.
Concentrations of LH, FSH and progesterone in plasma samples were determined by radioimmunoassay, as described previously (Thompson et al., 1983a,b,d) . Concentrations of testosterone in the samples drawn 8 h after the first antiserum injection were determined as described by Thompson and Honey (1984) . Concentrations of estradiol in plasma during estrus were determined as described by Koren-9 man et al. (1974) . In addition, the same estrous samples were assessed for total estrogen concentration as described by Thompson et al. (1985) . Tritiated testosterone binding was determined for plasma as described by Walker et al. (1984) . The specific activity of the tritiated testosterone was 99.0 Ci/mmol; 38,000 dprn (49.8 pg) were incubated with 10 /al of plasma per tube in duplicate. Picograms of labeled testosterone bound by 10/al of plasma were converted to ng bound/ml plasma (figure 1). Plasma samples drawn on the first and last days of Estrus III from control and androgenimmunized mares were used in two in vitro assessments of testosterone, estradiol and progesterone bioavailability. The first procedure consisted of equilibrium dialysis performed as described by Westphal (1971) . Plasma samples were diluted 1:5, and .5-ml aliquots were incubated in dialysis sacks at 38 C for 18 h in the presence of tritiated testosterone, estradiol or progesterone. The second procedure tested the effect of the plasma samples on tritiated testosterone, estradiol and progesterone uptake by slices of fresh sheep liver. Liver slices of approximately 50 mg each were incubated at 38 C in 1.0 ml of plasma containing 40,000 dpm of tritiated testosterone, estradiol or progesterone for 4.0 h. The slices were then removed, blotted and extracted with toluenebased scintillation cocktail for 12 h. No radioactivity remained in the tissue after extraction. The number of dpm in each extract was determined by liquid scintillation counting; quench correction was performed by the method of internal standardization.
For the 12 mares, the shortest duration of Estrus III was 3 d and of Diestrus III was 12 d; thus, data for the last 3 d of Estrus III and first 12 d of Diestrus III were used in the analysis of variance of hormonal concentrations. Tritiated testosterone binding was analyzed for samples drawn from 1 d before antiserum injection through 21 d after the initial injection. The analyses of variance took into account the repetitive nature of the sampling (split-plot design; Gill and Hafs, 1971) ; differences between groups for each time period were tested by the LSD procedure (Steel and Torrie, 1980) . Ovarian characteristics from the last 2 d of rectal palpation were analyzed by split-plot analysis of variance. Interval to estrus and duration of estrus were each analyzed by one-way analysis of variance (Steel and Torrie, 1980) .
Results
The abilities relative to testosterone of various steroids to inhibit the binding of tritiated testosterone to the antiserum used in this experiment are presented in table 1. The greatest inhibition was obtained with dihydrotestosterone (DHT; 52%). Lesser inhibition was obtained with the two other androgens tested, 5a-androstane-3a,17fl-diol (8.6%) and androst-4-ene-3,17-dione (1.2%). Estrogens, glucocorticolds and progesterone cross-reacted less than .1%.
Injection of antiserum generated against testosterone-BSA into the androgen-immunized mares resulted in an immediate increase (P<.01) in tritiated testosterone binding in plasma relative to control mares (figure 1). Moreover, this binding remained high during the period equivalent to Diestrus III and was still elevated (P<.01) 21 d after the initial injection. Tritiated testosterone binding in plasma of control mares was low and constant throughout this period.
Plasma concentrations of testosterone were greater (P<.05) in androgen-immunized mares than in control mares 8 h after the first antiserum injection (table 2) . Neither mean estradiol concentrations during the last 4 d of estrus, nor peak estradiol concentrations during estrus, differed between groups (P>.10; table 2). Results for concentrations of total estrogens were virtually identical to those for estradiol (data not shown). Testosterone binding as determined by equilibrium dialysis was greater (P<.001) in androgen-immunized mares than in control mares for plasma samples drawn on the first and last days of Estrus III (table 2) . In contrast, the binding of estradiol and progesterone in plasma was not affected (P>.10) by androgen immunization. In vitro liver uptake of tritiated testosterone was reduced (P<.001) by plasma of androgenimmunized mares relative to that of control mares, whereas liver uptake of radiolabeled estradiol and progesterone did not differ (P>.10) for plasma samples from the two groups (table 2) . aAntiserum was generated in a pony against testosterone-3-BSA and was assessed at a dilution that bound approximately 30% of 40,000 dpm (52 pg) of tritiated testosterone.
bRelative activity was determined at 50% displacement of tritiated testosterone. bTotal of bound and free. Mean estradiol concentrations include data from last 4 d of estrus; peak estradiol concentrations represent the highest concentrations occurring during estrus for each mare; testosterone concentrations were determined for blood sample drawn 8 h after antiserum injection.
CDetermined at 38 C. Plasma samples from the first and last day of estrus were assessed; there was no effect of day and no treatment • day interaction (P~.lO) for either group for any steroid.
*P~.05.
**P<.001.

Estrous and ovarian characteristics for Estrus
III are presented in table 3. There was no effect (P>.10) of passive immunization against testosterone on any characteristic. Averaged over all mares, the number of follicles present on both ovaries was smaller (P<.05) for the last palpation compared with that 2 d earlier.
Concentrations of FSH in plasma for the last 3 d of Estrus IlI and the first 12 d of Diestrus
III were not affected (P>.10) by passive immunization against androgen (figure 2). Averaged over all mares, concentrations of FSH did vary (P<.01) during the estrous cycle; concentrations were lowest during estrus and increased to a maximum on d 6 of diestrus.
Concentrations of LH in plasma a/so varied (P<.01) during the estrous cycle averaged over both groups of mares (figure 2); concentrations were high during estrus, reached a maximum on the first day of diestrus and gradually declined thereafter. Moreover, LH concentrations were higher (P<.05) in androgen-immunized mares than in control mares during the last 2 d of Estrus III and the first 4 d of Diestrus III (figure 2).
Concentrations of progesterone in plasma varied (P< .01) during the estrous cycle averaged over all mares (figure 3). There was no effect There was a treatment X time interaction (P<.05) for LH concentrations in the analysis of variance; asterisks indicate periods during which groups differed. Pooled SE from the analyses of variance were 2.9 and 1.9 ng/ml for PSH and LH concentrations, respectively.
(P>.10) of passive immunization against androgen on progesterone concentrations.
Discussion
The antiserum used in this experiment cross-reacted significantly with the major metabolite of testosterone, DHT, and to a lesser degree with the two other androgens tested. This is common for antisera generated against 4-ene-3-keto steroids conjugated at carbon-3 (Niswender, 1973; Auletta et al., 1979) . Regardless of the site of conjugation, most testosterone antisera cross-react to a significant degree with DHT; thus, our strategy was to maximize the cross-reactivity with DHT by using the 3-conjugate so that the antiserum would bind the two androgens that are most biologically active in most systems (Mainwaring, 1977) .
The dosage of antiserum injected into each mare was calculated such that the final concentration after mixing would be similar to the average response obtained after active immunization against steroids Walker et al., 1984; Thompson et al., 1985) . The binding of tritiated testosterone by plasma (figure 1) from the androgen-immunized mares was in fact similar to the binding reported in those earlier experiments, which There was no effect of treatment (P>.10) on progesterone concentrations. Pooled SE from the analysis of variance was 1.2 ng/ml. indicated that excess (unbound) antibodies were present throughout estrus and diestrus.
Moreover, the fact that these antibodies resulted in a net reduction in testosterone bioavailability to target tissues was confirmed by the two in vitro assessments of binding. That is, equilibrium dialysis indicated that more testosterone was bound by plasma of androgenimmunized mares than of control mares. And even though total testosterone concentrations were higher in androgen-immunized mares (table 2), the calculated amount of unbound hormone was actually less (1.3 vs 3.2 pg/ml). In addition, liver uptake of labeled testosterone was reduced by 70% in the presence of plasma of androgen-immunized mares relative to controls. These in vitro trials also confirmed that the anti-androgen antibodies did not perturb estradiol-or progesterone-binding characteristics, which is in good agreement with the cross-reactivity data in table 1.
The effects of LH secretion reported herein are similar to those reported for ewes actively immunized against testosterone Scaramuzzi et al., 1981) . That is, passive immunization of these cyclic mares against androgen 1 to 3 d before the onset of estrus increased LH concentrations during estrus and early diestrus. Thus, we conclude that androgens are in some way involved with the regulation of LH secretion at this stage of the estrous cycle. Whether this involvement is direct or indirect needs to be determined. If the androgens secreted by the ovaries at estrus (Noden et al., 1975; Silberzahn et al., 1978) exert a negative influence directly on the hypothalamic-hypophyseal axis, then partial removal of this negative feedback by immunization would increase LH secretion. In support of this alternative, we have shown previously (Thompson et al., 1983c ) that treatment of estrous mares with testosterone propionate reduced LH secretion, and like the present experiment, had no effect on ovulation or subsequent progesterone secretion. Alternatively, androgens in the follicle appear to be involved in the regulation of estrogen production in addition to being precursors to estrogens (reviewed by Hillensjo, 1981) . Although estrogens appear to stimulate LH secretion in the mare (Pattison et al., 1974-; Ginther, 1979) , concentrations of estradiol and total estrogens were not altered by androgen immunization in the present experiment, thus it is unlikely that the effects of immunization on LH secretion were mediated through estrogen secretion.
The present results do not support the hypothesis that androgens from the ovary during estrus stimulate FSH secretion during the subsequent diestrus in mares (Thompson et al., 1983d) . Thus, the stimulation of FSH secretion during diestrus reported by Thompson et al. (1983d) was possibly a pharmacologic rather than physiologic effect of testosterone. Alternatively, it may be that the short-term immunization of mares in the present experiment was not sufficient to detect an androgen involvement with FSH secretion. Active immunization of mares in the long-term, as reported for ewes Scaramuzzi et al., 1981) and heifers (Wise and Schanbacher, 1983) , needs to be done before a physiologic androgen-FSH interaction can be dismissed.
Unlike the ewe and heifer (Scaramuzzi et al., 1981; Wise and Schanbacher, 1983) , there was no effect in these mares of immunization against androgen on ovarian or estrous characteristics. There were fewer palpable follicles later in estrus relative to early estrus averaged over all mares, which was likely due to the domination of the ovulatory follicle (Ginther, 1979) . As for FSH secretion, long-term active immunization against androgens might reveal effects on ovarian characteristics that shortterm immunization ~lid not detect.
Although LH concentrations in the androgen-immunized mares were stimulated during estrus and early diestrus relative to control mares, there was no difference between groups for progesterone concentrations at any time. In a previous experiment (Thompson et al., 1983c) , suppression of LH concentrations during this same period with TP had no effect on progesterone concentrations during the subsequent diestrus. Thus, as we concluded in the previous report, the high concentrations of LH in plasma of the mare during the periovulatory period appear to be in excess of that required for ovulation and normal luteal function.
In conclusion, androgens appear to be involved in some way with the regulation of LH secretion in the mare during estrus and early diestrus. In contrast, no involvement of androgens with FSH secretion was found under the short-term conditions of this experiment.
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